From The Industry Experts

  1. Solving Trial Enrollment Challenges With Direct-To-Patient Recruitment 1/6/2026

    Overcome enrollment bottlenecks by shifting from site-centric models to tech-enabled, direct-to-patient outreach.

  2. How Rescue Studies Use Direct-To-Patient Strategies To Accelerate Clinical Trial Enrollment 1/6/2026

    If your trial struggles to overcome enrollment bottlenecks, a tech-enabled rescue strategy could be the solution.

  3. Why We Need To Look To The Future Of Clinical Trials 1/6/2026

    Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.

  4. How DCTs Can Shift The Pediatric Rare Disease Research Landscape 1/6/2026

    DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.

  5. Reducing The Burden Of Patient Retention And Improving Continuity 1/6/2026

    Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.

  6. A New, AI-Augmented Horizon For Safety And Pharmacovigilance 1/6/2026

    Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.

  7. Psychiatric Drug Development Renaissance: With Familiar Risks 1/6/2026

    Emerging psychiatric therapies bring hope, but progress is fragile. Biomarker-driven, mechanism-first approaches help overcome biological, regulatory, and commercial barriers.

  8. Trailblazing Clinical Drug Development In Dermatology 1/6/2026

    AI, imaging, and biomarkers are transforming trials, reducing subjectivity and improving sensitivity while enabling decentralized designs, faster timelines, and more precise insights.

  9. Clinical Research Trends And IRB Expectations For 2026 1/6/2026

    Oversight in 2026 requires adaptability as AI, consent standards, and regulatory uncertainty challenge sponsors and IRBs to balance ethics with innovation through proactive planning and collaboration.

  10. Medical Insight's Role In Early-Phase Clinical Development 1/6/2026

    Medical insight reduces risk, strengthens protocols, and accelerates timelines — enhancing safety, feasibility, and collaboration for successful trials and reliable outcomes.